
Elevation Oncology, Inc.
Elevation Oncology, Inc. (ELEV) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · ELEV · as of Jun 9, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
0
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
Elevation Oncology, Inc. insiders have shown mixed buying and selling activity over the past 12 Months.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
ELEV insider buying and selling by quarter
ELEV insider selling · ELEV insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Active insiders
Most active in past 12 months · ELEV ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
ELEV executive sell shares · ELEV board member insider trading · ELEV insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jul 23, 2025 | CLACKSON TIMOTHY P Director | Other | 47,330 | $17K | Form 4 |
| Jul 23, 2025 | Furlong Tammy CHIEF FINANCIAL OFFICER | Other | 37,957 | $14K | Form 4 |
| Jun 16, 2025 | Ferra Joseph J Jr CHIEF EXECUTIVE OFFICER · Director | Option | 12,560 | — | Form 4 |
| Jun 16, 2025 | Ferra Joseph J Jr CHIEF EXECUTIVE OFFICER · Director | Other | 4,627 | $2K | Form 4 |
| May 15, 2025 | Furlong Tammy CHIEF FINANCIAL OFFICER | Option | 2,643 | — | Form 4 |
| May 15, 2025 | Furlong Tammy CHIEF FINANCIAL OFFICER | Other | 784 | $235 | Form 4 |
| May 15, 2025 | Ferra Joseph J Jr CHIEF EXECUTIVE OFFICER · Director | Option | 6,250 | — | Form 4 |
| May 15, 2025 | Ferra Joseph J Jr CHIEF EXECUTIVE OFFICER · Director | Other | 2,303 | $690 | Form 4 |
| Mar 16, 2025 | Ferra Joseph J Jr CHIEF EXECUTIVE OFFICER · Director | Option | 12,562 | — | Form 4 |
| Mar 16, 2025 | Ferra Joseph J Jr CHIEF EXECUTIVE OFFICER · Director | Other | 4,628 | $2K | Form 4 |
| Feb 15, 2025 | Jansen Valerie Malyvanh CHIEF MEDICAL OFFICER | Option | 17,500 | — | Form 4 |
| Feb 15, 2025 | Jansen Valerie Malyvanh CHIEF MEDICAL OFFICER | Other | 5,189 | $3K | Form 4 |
| Feb 15, 2025 | Furlong Tammy CHIEF FINANCIAL OFFICER | Option | 9,375 | — | Form 4 |
| Feb 15, 2025 | Furlong Tammy CHIEF FINANCIAL OFFICER | Option | 300 | — | Form 4 |
| Feb 15, 2025 | Furlong Tammy CHIEF FINANCIAL OFFICER | Other | 89 | $60 | Form 4 |
| Feb 15, 2025 | Furlong Tammy CHIEF FINANCIAL OFFICER | Other | 2,780 | $2K | Form 4 |
| Feb 15, 2025 | Dornan David CHIEF SCIENTIFIC OFFICER | Option | 9,375 | — | Form 4 |
| Feb 15, 2025 | Dornan David CHIEF SCIENTIFIC OFFICER | Other | 4,152 | $3K | Form 4 |
| Feb 15, 2025 | Ferra Joseph J Jr CHIEF EXECUTIVE OFFICER · Director | Option | 25,000 | — | Form 4 |
| Feb 15, 2025 | Ferra Joseph J Jr CHIEF EXECUTIVE OFFICER · Director | Other | 9,211 | $6K | Form 4 |
| Dec 16, 2024 | Ferra Joseph J Jr CHIEF EXECUTIVE OFFICER · Director | Option | 12,563 | — | Form 4 |
| Dec 16, 2024 | Ferra Joseph J Jr CHIEF EXECUTIVE OFFICER · Director | Other | 4,629 | $3K | Form 4 |
| Nov 15, 2024 | Furlong Tammy CHIEF FINANCIAL OFFICER | Option | 300 | — | Form 4 |
| Nov 15, 2024 | Furlong Tammy CHIEF FINANCIAL OFFICER | Other | 98 | $52 | Form 4 |
| Sep 16, 2024 | Ferra Joseph J Jr CHIEF EXECUTIVE OFFICER · Director | Option | 12,562 | — | Form 4 |
Furlong Tammy
CHIEF FINANCIAL OFFICER
Date
Jul 23
Shares
37,957
Price
$0.36
Value
$14K
Ferra Joseph J Jr
CHIEF EXECUTIVE OFFICER · Director
Date
Jun 16
Shares
12,560
Price
—
Value
—
Ferra Joseph J Jr
CHIEF EXECUTIVE OFFICER · Director
Date
Jun 16
Shares
4,627
Price
$0.39
Value
$2K
Furlong Tammy
CHIEF FINANCIAL OFFICER
Date
May 15
Shares
784
Price
$0.30
Value
$235
Ferra Joseph J Jr
CHIEF EXECUTIVE OFFICER · Director
Date
May 15
Shares
6,250
Price
—
Value
—
Ferra Joseph J Jr
CHIEF EXECUTIVE OFFICER · Director
Date
May 15
Shares
2,303
Price
$0.30
Value
$690
Ferra Joseph J Jr
CHIEF EXECUTIVE OFFICER · Director
Date
Mar 16
Shares
12,562
Price
—
Value
—
Ferra Joseph J Jr
CHIEF EXECUTIVE OFFICER · Director
Date
Mar 16
Shares
4,628
Price
$0.53
Value
$2K
Jansen Valerie Malyvanh
CHIEF MEDICAL OFFICER
Date
Feb 15
Shares
17,500
Price
—
Value
—
Jansen Valerie Malyvanh
CHIEF MEDICAL OFFICER
Date
Feb 15
Shares
5,189
Price
$0.67
Value
$3K
Furlong Tammy
CHIEF FINANCIAL OFFICER
Date
Feb 15
Shares
2,780
Price
$0.67
Value
$2K
Dornan David
CHIEF SCIENTIFIC OFFICER
Date
Feb 15
Shares
4,152
Price
$0.67
Value
$3K
Ferra Joseph J Jr
CHIEF EXECUTIVE OFFICER · Director
Date
Feb 15
Shares
25,000
Price
—
Value
—
Ferra Joseph J Jr
CHIEF EXECUTIVE OFFICER · Director
Date
Feb 15
Shares
9,211
Price
$0.67
Value
$6K
Ferra Joseph J Jr
CHIEF EXECUTIVE OFFICER · Director
Date
Dec 16
Shares
12,563
Price
—
Value
—
Ferra Joseph J Jr
CHIEF EXECUTIVE OFFICER · Director
Date
Dec 16
Shares
4,629
Price
$0.64
Value
$3K
Ferra Joseph J Jr
CHIEF EXECUTIVE OFFICER · Director
Date
Sep 16
Shares
12,562
Price
—
Value
—
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About ELEV insider trading
ELEV insider trades
Elevation Oncology, Inc. (ELEV) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Ferra Joseph J Jr (CHIEF EXECUTIVE OFFICER · Director), CLACKSON TIMOTHY P (Director), Furlong Tammy (CHIEF FINANCIAL OFFICER). Over the past 12 months, 3 insiders have filed transactions with the SEC. ELEV insiders have been mixed buying and selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Elevation Oncology, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
ELEV insider trading · 5 questionsThe insiders of Elevation Oncology, Inc. (ELEV) include executives and directors such as Ferra Joseph J Jr (CHIEF EXECUTIVE OFFICER · Director), CLACKSON TIMOTHY P (Director), Furlong Tammy (CHIEF FINANCIAL OFFICER), among others. Over the past 12 months, 3 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026